Share your views on the clinical priorities for cancer risk prediction
Cancer Data Driven Detection (CD3) is a proposed new, national research initiative dedicated to using data to revolutionise our understanding of cancer risk and to allow early interception of cancers.
They are organising a consultation which aims to generate insights into how improvements in cancer risk prediction should be targeted to ensure most benefit to routine clinical practice.
They want to hear from healthcare and allied professionals about their current use of cancer risk prediction tools or models, the areas of clinical decision-making they feel could benefit most from improved risk prediction, and which cancers should be prioritised.
Deadline: 30 January 2024